Joint Formulary & PAD

Tiotropium (Braltus Zonda) - Chronic Obstructive Pulmonary Disease (COPD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Inhaler (dry powder)
Associated Icons :
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Tiotropium (Braltus Zonda)
Indication :
Chronic Obstructive Pulmonary Disease (COPD)
Group Name :
LAMA
Keywords :
LAMAs, chronic obstructive pulmonary disease, respiratory, long-acting muscarinic antagonist
Brand Names Include :
Braltus Zonda
Important Information :

Safety concerns with device. Combination of LAMA and LABA recommended in COPD.

Not for initiation in new patients.

Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
3

Committee Recommendations (1)

The tiotropium Braltus device is NOT a locally preferred option. See below for preferred devices.

The locally preferred LAMA devices are as follows:

  • Spiriva Respimat (tiotropium soft mist inhaler). Re-usable device.
  • Incruse Ellipta (Umeclidinium DPI)
  • Seebri Breezhaler (Glycopyrronium DPI)
  • Eklira Genuair (Aclidinium DPI)

Devices should be prescribed by BRAND

See full COPD guidelines for more information

Other Indications

Below are listed other indications that Tiotropium (Braltus Zonda) is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Chronic Obstructive Pulmonary Disease (COPD).